Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RP 62203

Known as: RP-62203 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
The effects of mesulergine (100 and 200 microg/kg s.c.), SB 206553 (1 and 2.5 mg/kg i.p.), RP 62203 (2.5 and 4 mg/kg i.p.) and… Expand
Is this relevant?
1997
1997
To study the role of 5-HT2A and 5-HT2C receptor subtypes in anxiety, the behavioral effects of drugs that either block or… Expand
Is this relevant?
1996
1996
The dopamine D4 receptor is a potential target for novel antipsychotic drugs. Most available compounds with affinity for the… Expand
Is this relevant?
1993
1993
The binding properties and localization of [3H]RP 62203, a novel ligand for 5-HT2 receptors, were investigated on rat brain… Expand
Is this relevant?
1993
1993
In this study, quantitative autoradiography was used to determine the selectivity of RP 62203, a novel naphtosultam derivative… Expand
Is this relevant?
1992
1992
1. RP 62203 (2-[3-(4-(4-fluorophenyl)-piperazinyl)propyl]naphto[1,8- ca]isothiazole-1,1-dioxide) is a novel naphtosultam… Expand
Is this relevant?
1992
1992
RP 62203, a naphtosultam derivative, is an antagonist at the 5-hydroxytryptamine2 (HT2) receptor. The sleep pattern of rats… Expand
Is this relevant?
1991
1991
The precise role of serotonin (5-HT) in anxiety remains unclear. We report here on the effects of RP 62203, a new 5-HT2… Expand
Is this relevant?
1991
1991
The influence of the novel 5-hydroxytryptamine2 (5-HT2) receptor antagonist, RP 62203, on serotoninergic neurotransmission was… Expand
Is this relevant?